Debt to EBITDA ratio Analysis of Lyra Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of LYRA
Dec-23-0.089Very Poor Debt to EBITDA | Dec-22-0.0283Very Poor Debt to EBITDA | Growth-212.75% |
Debt to EBITDA Analysis of Lyra Therapeutics Inc
| Debt to EBITDA Ratio of LYRA drastically fell by -212.75 % this year. |
| Debt to EBITDA Ratio with value of -0.0247 was highest in Year Dec-21 in last Five Years. |
| Debt to EBITDA Ratio with value of -0.089 was lowest in Year Dec-23 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.089 is lower than Average Debt to EBITDA of -0.0483 in last five years. |
Other Debt to EBITDA Related Info of LYRA that may interest you.
Lyra Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| LYRA | 0.328 | 0.3316 | 1.09 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| No Significant Stability | |
FY - Historical Debt to EBITDA of Lyra Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
|---|---|---|---|---|---|---|
| Debt to EBITDA | -0.089 | -0.0283 | -0.0247 | -0.0447 | -0.055 | 0 |
| Change | -212.75 % | -14.75 % | 44.79 % | 19.04 % |
FY Chart of Debt to EBITDA of Lyra Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)